X
18Sep

Government Continues to Closely Scrutinize Pharmaceutical Marketing Practices

On September 4, 2019 the Department of Justice (DOJ) announced a $15.4 million settlement with pharmaceutical company Mallinckrodt ARD LLC (Mallinckrodt) to resolve alleged violations of the Anti-Kickback Statute (AKS) in two whistleblower suits...
By: Robinson+Cole Health Law Diagnosis
Source Url: https://www.jdsupra.com/legalnews/government-continues-to-closely-82799/

Related

Germany’s Foreign Direct Investment Regime: Further Changes Ahead

On November 29, 2018, the German Minister for Economic Affairs, Peter Altmaier, presented its “Nati...

Read More >

It's Time to Reconsider the Term "Whistleblower"

The more things change, the more things stay the same. As compliance matures as an industry, we some...

Read More >

Is Your Indemnity Agreement Enforceable? How to Not Miss Out on this Critical Step in Risk Management

Generally, indemnity agreements in construction contracts are a promise by which one party (the inde...

Read More >

HR Quick Take: Workplace Injuries and Drug Tests

Q: When an employee is injured on the job, can we drug test them? A: This is a common question pose...

Read More >

Negotiating and Enforcing Anti-Disparagement Clauses: A Primer for Employers

Severance and litigation settlement agreements often include a provision that prohibits one or more ...

Read More >

COVID-19: The UK Logistics Sector: Future M&A Trends in a Post-Pandemic Environment

Introduction - Nothing focuses the mind more than when you cannot obtain food which, as Maslow's hie...

Read More >